Search research articles
Contact Us
Filters
Showing results (1-10 of 132) with videos related to
Page
of 14
Sort By:
Current Controlled Trials in Cardiovascular Medicine
|
November 21, 2001
What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
Jon Kobashigawa
Frontiers in Transplantation
|
November 21, 2024
Paul I. Terasaki, Ph.D: a pioneer in transplant medicine and a dedicated philanthropist
Jon Kobashigawa
Personalized Medicine
|
May 17, 2018
Detecting rejection in cardiac transplantation: applications of genomic medicine
Rajeev Mohan, Jon Kobashigawa
Current Opinion in Organ Transplantation
|
March 18, 2017
Current concepts for sensitized patients before transplantation
Dael Geft, Jon Kobashigawa
Current Opinion in Organ Transplantation
|
July 14, 2012
The use of the calculated panel-reactive antibody and virtual crossmatch in heart transplantation
David Chang, Jon Kobashigawa
Clinical Transplants
|
May 18, 2017
A Review of the Management of Pregnancy After Cardiac Transplantation
Diane D Tran, Jon Kobashigawa
Current Opinion in Cardiology
|
April 13, 2004
Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy
Michael C Fishbein, Jon Kobashigawa
Circulation Journal : Official Journal of the Japanese Circulation Society
|
August 23, 2021
Molecular Diagnosis of Rejection in Heart Transplantation
Lillian Benck, Takuma Sato, Jon Kobashigawa
Clinical Transplantation
|
January 26, 2008
Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity
Stuart M Flechner, Jon Kobashigawa, Goran Klintmalm
JACC. Cardiovascular Interventions
|
May 26, 2009
Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy
Michael S Lee, Jon Kobashigawa, Jonathan Tobis
Page
of 14
Search research articles
Search
Showing results (1-10 of 132) with videos related to
Sort By:
Page
of 14
Current Controlled Trials in Cardiovascular Medicine
|
November 21, 2001
What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
Jon Kobashigawa
Frontiers in Transplantation
|
November 21, 2024
Paul I. Terasaki, Ph.D: a pioneer in transplant medicine and a dedicated philanthropist
Jon Kobashigawa
Personalized Medicine
|
May 17, 2018
Detecting rejection in cardiac transplantation: applications of genomic medicine
Rajeev Mohan, Jon Kobashigawa
Current Opinion in Organ Transplantation
|
March 18, 2017
Current concepts for sensitized patients before transplantation
Dael Geft, Jon Kobashigawa
Current Opinion in Organ Transplantation
|
July 14, 2012
The use of the calculated panel-reactive antibody and virtual crossmatch in heart transplantation
David Chang, Jon Kobashigawa
Clinical Transplants
|
May 18, 2017
A Review of the Management of Pregnancy After Cardiac Transplantation
Diane D Tran, Jon Kobashigawa
Current Opinion in Cardiology
|
April 13, 2004
Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy
Michael C Fishbein, Jon Kobashigawa
Circulation Journal : Official Journal of the Japanese Circulation Society
|
August 23, 2021
Molecular Diagnosis of Rejection in Heart Transplantation
Lillian Benck, Takuma Sato, Jon Kobashigawa
Clinical Transplantation
|
January 26, 2008
Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity
Stuart M Flechner, Jon Kobashigawa, Goran Klintmalm
JACC. Cardiovascular Interventions
|
May 26, 2009
Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy
Michael S Lee, Jon Kobashigawa, Jonathan Tobis
Page
of 14